Fuse Medical reports FY 2022 net income of $3.1M, swing from prior-year loss; revenue down 9%

Fuse Medical, Inc.

2023-Q1 EPS reported $0.00 revenue$3,984,455

Net revenue $18.6M (-9% YoY); gross profit margin improved to 62% from 58%.
Net income of $3.1M vs net loss of $1.59M in FY 2021, a swing of $4.69M.
Adjusted EBITDA loss narrowed to ~$1.0M from ~$2.0M (improvement of ~50%).
SG&A down 7% to $6.5M; commissions expense down 20% to $5.7M.
CEO Reeg: focus in 2023 on design, development, commercialization, and expanding direct sales force.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Fuse Medical, Inc. reported the year ended December 31, 2022 results: revenue $18.6 million, net income $3.1 million.

Period: the year ended December 31, 2022
Revenue: $18.6 million
Net income: $3.1 million
Result: reported results

Exact text from the filing

Net revenues for the year ended December 31, 2022 were $18.6 million

View on SEC.gov

Browse all earnings releases →

Fuse Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001564590-23-005823

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.